Study in Subjects With Moderate Atopic Dermatitis

Clinical trial NCT03859986 · UNKNOWN

Trial details

NCT number: NCT03859986
Sponsor: Ralexar Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Atopic Dermatitis Eczema

Start date: 2019-03-08
Primary completion: 2020-01-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.